Literature DB >> 23241715

[Relationships between sleep and addiction].

Francesca Cañellas, Luis de Lecea.   

Abstract

While it is well known that there is an interaction between sleep disorders and substance abuse, it is certainly more complex than was previously thought. There is a positive relationship both between having a substance use disorder and suffering from a sleep disorder, and vice versa. The effects on sleep depend on the substance used, but it has been shown that both during use and in withdrawal periods consumers have various sleep problems, and basically more fragmented sleep. We know that sleep problems must be taken into account to prevent addiction relapses. Recent research shows that the hypocretinergic system defined by neuropeptide hypocretin / orexin (Hcrt / ox), located in the lateral hypothalamus and involved in, among other things, the regulation of the sleep-wake cycle, may play an important role in addictive behaviors. Different studies have demonstrated interactions between the hypocretinergic system, acute response to stress circuits and reward systems. We also know that selective optogenetic activation of the hypocretinergic system increases the probability of transition from sleep to wakefulness, and is sufficient for initiating an addictive compulsive behavior relapse. Hypocretinergic system activation could explain the hyperarousal associated with stress and addiction. Improved knowledge of this interaction would help us to understand better the mechanisms of addiction and find new strategies for the treatment of addictions.

Entities:  

Mesh:

Year:  2012        PMID: 23241715      PMCID: PMC5047372     

Source DB:  PubMed          Journal:  Adicciones        ISSN: 0214-4840            Impact factor:   2.979


  17 in total

Review 1.  The hypocretins: setting the arousal threshold.

Authors:  J Gregor Sutcliffe; Luis de Lecea
Journal:  Nat Rev Neurosci       Date:  2002-05       Impact factor: 34.870

2.  Persistent insomnia, abstinence, and moderate drinking in alcohol-dependent individuals.

Authors:  Kirk J Brower; Amy Krentzman; Elizabeth A R Robinson
Journal:  Am J Addict       Date:  2011-07-18

Review 3.  Pharmacological treatment of insomnia in alcohol recovery: a systematic review.

Authors:  Bhanu Prakash Kolla; Meghna Prabhdas Mansukhani; Terry Schneekloth
Journal:  Alcohol Alcohol       Date:  2011-06-29       Impact factor: 2.826

Review 4.  The hypocretin/orexin system: implications for drug reward and relapse.

Authors:  Ainhoa Plaza-Zabala; Rafael Maldonado; Fernando Berrendero
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

5.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

7.  Association between nocturnal vagal tone and sleep depth, sleep quality, and fatigue in alcohol dependence.

Authors:  Michael R Irwin; Edwin M Valladares; Sarosh Motivala; Julian F Thayer; Cindy L Ehlers
Journal:  Psychosom Med       Date:  2006 Jan-Feb       Impact factor: 4.312

Review 8.  Hypocretin/orexin, sleep and narcolepsy.

Authors:  M Hungs; E Mignot
Journal:  Bioessays       Date:  2001-05       Impact factor: 4.345

9.  [Sleep disorders and the consumption of hypnotics on the island of Mallorca].

Authors:  F Cañellas Dols; J Ochogavia Cánaves; J Llobera Cánaves; A Palmer Pol; J Castell Colom; C Iglesias Tamargo
Journal:  Rev Clin Esp       Date:  1998-11       Impact factor: 1.556

10.  Neural substrates of awakening probed with optogenetic control of hypocretin neurons.

Authors:  Antoine R Adamantidis; Feng Zhang; Alexander M Aravanis; Karl Deisseroth; Luis de Lecea
Journal:  Nature       Date:  2007-10-17       Impact factor: 49.962

View more
  6 in total

Review 1.  Aging, circadian rhythms and depressive disorders: a review.

Authors:  Inês Campos Costa; Hugo Nogueira Carvalho; Lia Fernandes
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

2.  Treatment of cocaine addiction with amphetamine, a sleep-suppressant drug: associative learning, sleep patterns and clinical perspectives.

Authors:  Laís F Berro; Roberto Frussa-Filho; Sergio Tufik; Monica L Andersen
Journal:  Psychopharmacology (Berl)       Date:  2013-12-04       Impact factor: 4.530

3.  Sleep Quality and Sleep Disturbance Perception in Dual Disorder Patients.

Authors:  Gianina Luca; Lola Peris
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

4.  Polysomnographic survey of sleep architecture in patients with methamphetamine dependence during remission.

Authors:  Amir Rezaei-Ardani; Fariborz Rezaei-Talab; Lahya Afshari-Saleh; Hadi Asad-Pour; Zahra Amjadi-Goojgi
Journal:  Sleep Sci       Date:  2021 Jan-Mar

5.  Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder.

Authors:  Jake Valeri; Sinead M O'Donovan; Wei Wang; David Sinclair; Ratna Bollavarapu; Barbara Gisabella; Donna Platt; Craig Stockmeier; Harry Pantazopoulos
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

6.  Mouse Gambling Task reveals differential effects of acute sleep debt on decision-making and associated neurochemical changes.

Authors:  Elsa Pittaras; Jacques Callebert; Rodolphe Dorey; Mounir Chennaoui; Sylvie Granon; Arnaud Rabat
Journal:  Sleep       Date:  2018-11-01       Impact factor: 5.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.